Clinical Trials Browser

Withdrawn × Urinary Bladder Neoplasms × Gemcitabine × Clear all

NCT00014287 2013-12-19

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

Phase 1 Withdrawn

Urinary Bladder Neoplasms